Published on
Apr 6, 2021
Op-Ed: With proper patent protection, vaccines offer plenty of promise
Since the start of the pandemic, leading drug makers such as Pfizer, Moderna, AstraZeneca, and Johnson & Johnson have relied on robust intellectual property (IP) protections in developing coronavirus vaccines. Because of the patent protections afforded …
Source:
The Center Square
-
Right-wing
